How many potential benefits does the cannabis plant with its 550+ chemical compounds hold for our health?

No one knows, but as scientists have increased opportunities to research it, each new study provides another piece of this large puzzle. This time, researchers at the Universities of Utah and Northern Colorado analyzed the effects of cannabigerol (CBG) on fibrosis connected to nonalcoholic fatty liver disease (NAFLD), reported Shelby McDaniel, referring to a study appearing in MDPI, a publisher of open-access scientific journals.

What Is CBG?

Even though THC and CBD are the cannabinoids most researched and covered by the media, CBG is often considered the mother cannabinoid because all other cannabinoids are derived from it. It is the chemical precursor to cannabinoids such as THC, CBD, CBC and …

Full story available on